Omeros Corporation (OMER)

[1hb]

Dr. Thorfin, presently I believe they are paid separately for the eye product until Dec 31 this year. They expect to get approved for J code (or is it C code for medicare) to continue that way and I saw something about them hearing that decision soon?! which if positive should at least add a point or two but if the FDA rules against that and it has to be bundled in with the surgery then it could cut revenue by a lot, even maybe 40%. With politics on costs what it is I will be glad when we know that decision is out in our favor..also,
while I get the math on no secondary it does make me a bit concerned that sometimes with this kind of jump they just HAVE to take advantage of it and raise some amount as smallish amount should not dilute much. Personally I would want to if in their shoes...to take advantage of this run they will need to do it soon UNLESS they know pretty immediate news will be out like EU partner....interesting to see. Also, REALLY want your opinion on buyout possiblities too doc. Thanks !